no-3-2022—Page 2

no-3-2022SHARE / this issue Key figures Shareholder information Financial calendar Cover photo: Rebecca Commanda lives with type 2 diabetes Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes 2 SHARE Magazine • 3/2022Page 1Page 3